Additionally, a 2020 mm specimen was extracted from the non-damaged tissue of the upper back for the purpose of weight determination at days 1, 2, and 3 following euthanization
receiving research grants from Chief Scientist Office, Diabetes UK, European Commission, IQVIA, Juvenile Diabetes Research Foundation and Medical Research Council
Multifunctionality and possible medical application of BPC-157: literature and patent review (2025) Current Pharmaceutical Design (PMC) Sikiric P et al
A 2025 Phase I trial (Lee & Burgess, 2025) demonstrated that IV BPC-157 doses up to 20 mg were tolerated in healthy volunteers with no serious adverse events
Everything below is framed as the documented research protocol, for research use only , never as a prescription or a personal recommendation
Whats more, the study only tested treatment for approximately two months